PolyPid Ltd. (PYPD)
5.10
+0.12
(+2.31%)
USD |
NASDAQ |
Aug 25, 16:00
4.57
-0.53
(-10.39%)
After-Hours: 06:53
PolyPid Enterprise Value : 98.39M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 98.39M |
| August 24, 2026 | 96.06M |
| August 21, 2026 | 98.39M |
| August 20, 2026 | 97.99M |
| August 19, 2026 | 96.56M |
| August 18, 2026 | 90.88M |
| August 17, 2026 | 91.69M |
| August 14, 2026 | 91.08M |
| August 13, 2026 | 91.89M |
| August 12, 2026 | 93.11M |
| August 11, 2026 | 90.88M |
| August 10, 2026 | 91.69M |
| August 07, 2026 | 93.11M |
| August 06, 2026 | 92.50M |
| August 05, 2026 | 88.24M |
| August 04, 2026 | 85.19M |
| August 03, 2026 | 83.36M |
| July 31, 2026 | 81.94M |
| July 30, 2026 | 83.56M |
| July 29, 2026 | 77.67M |
| July 28, 2026 | 70.97M |
| July 27, 2026 | 75.64M |
| July 24, 2026 | 74.02M |
| July 23, 2026 | 80.92M |
| July 22, 2026 | 76.05M |
| Date | Value |
|---|---|
| July 21, 2026 | 70.77M |
| July 20, 2026 | 99.41M |
| July 17, 2026 | 103.88M |
| July 16, 2026 | 100.22M |
| July 15, 2026 | 100.63M |
| July 14, 2026 | 103.47M |
| July 13, 2026 | 97.17M |
| July 10, 2026 | 101.03M |
| July 09, 2026 | 104.89M |
| July 08, 2026 | 100.63M |
| July 07, 2026 | 103.06M |
| July 06, 2026 | 108.14M |
| July 02, 2026 | 96.77M |
| July 01, 2026 | 97.38M |
| June 30, 2026 | 97.99M |
| June 29, 2026 | 86.54M |
| June 26, 2026 | 82.32M |
| June 25, 2026 | 78.87M |
| June 24, 2026 | 82.51M |
| June 23, 2026 | 86.92M |
| June 22, 2026 | 89.60M |
| June 18, 2026 | 82.13M |
| June 17, 2026 | 78.67M |
| June 16, 2026 | 80.59M |
| June 15, 2026 | 80.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 57.61B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 141.64M |
| Purple Biotech Ltd. | -3.359M |
| Sol-Gel Technologies Ltd. | 220.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.849M |
| Total Expenses (Quarterly) | 7.849M |
| EPS Diluted (Quarterly) | -0.3467 |
| Earnings Yield | -29.06% |
| Normalized Earnings Yield | -29.06 |